These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 16088954)

  • 1. Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion.
    Brown AJ; Ritter CS; Weiskopf AS; Vouros P; Sasso GJ; Uskokovic MR; Wang G; Reddy GS
    J Cell Biochem; 2005 Oct; 96(3):569-78. PubMed ID: 16088954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
    Reddy GS; Rao DS; Siu-Caldera ML; Astecker N; Weiskopf A; Vouros P; Sasso GJ; Manchand PS; Uskokovic MR
    Arch Biochem Biophys; 2000 Nov; 383(2):197-205. PubMed ID: 11185554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion.
    Brown AJ; Ritter C; Slatopolsky E; Muralidharan KR; Okamura WH; Reddy GS
    J Cell Biochem; 1999 Apr; 73(1):106-13. PubMed ID: 10088729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
    Reddy GS; Robinson M; Wang G; Palmore GT; Gennaro L; Vouros P; De Clercq P; Vandewalle M; Young W; Ling S; Verstuyf A; Bouillon R
    Arch Biochem Biophys; 2007 Apr; 460(2):254-61. PubMed ID: 17196157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1.
    Astecker N; Bobrovnikova EA; Omdahl JL; Gennaro L; Vouros P; Schuster I; Uskokovic MR; Ishizuka S; Wang G; Reddy GS
    Arch Biochem Biophys; 2004 Nov; 431(2):261-70. PubMed ID: 15488475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell specificity and properties of the C-3 epimerization of Vitamin D3 metabolites.
    Kamao M; Tatematsu S; Sawada N; Sakaki T; Hatakeyama S; Kubodera N; Okano T
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):39-42. PubMed ID: 15225744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D3 polyunsaturated side-chain analogues (EB1089, GS1590) and the 20-epi-vitamin D3 analogue CB1393 suppress parathyroid hormone secretion and mRNA level in bovine parathyroid cells.
    Segersten U; Holm PK; Binderup L; Akerström G; Hellman P; Westin G
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):289-94. PubMed ID: 15120422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of selective 20-epi-vitamin D
    Flarakos CC; Weiskopf A; Robinson M; Wang G; Vouros P; Sasso GJ; Uskokovic MR; Reddy GS
    Steroids; 2017 Mar; 119():18-30. PubMed ID: 28089927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1alpha or C-24 hydroxylation.
    Kamao M; Tatematsu S; Hatakeyama S; Sakaki T; Sawada N; Inouye K; Ozono K; Kubodera N; Reddy GS; Okano T
    J Biol Chem; 2004 Apr; 279(16):15897-907. PubMed ID: 14757768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, stereochemistry, and biological activity of 1alpha,23,25-trihydroxy-24-oxovitamin D3, a major natural metabolite of 1alpha,25-dihydroxyvitamin D3.
    Lee NE; Reddy GS; Brown AJ; Williard PG
    Biochemistry; 1997 Aug; 36(31):9429-37. PubMed ID: 9235987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells.
    Brown AJ; Ritter CS; Knutson JC; Strugnell SA
    Nephrol Dial Transplant; 2006 Mar; 21(3):644-50. PubMed ID: 16221703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue specific metabolism of 1alpha,25-dihydroxy-20-epi-vitamin D3 into new metabolites with significant biological activity: studies in rat osteosarcoma cells (UMR 106 and ROS 17/2.8).
    Siu-Caldera ML; Rao DS; Astecker N; Weiskopf A; Vouros P; Konno K; Fujishima T; Takayama H; Peleg S; Reddy GS
    J Cell Biochem; 2001; 82(4):599-609. PubMed ID: 11500938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological activities of 14-epi-MART-10 and 14-epi-MART-11: implications for cancer and osteoporosis treatment.
    Kittaka A; Hara H; Takano M; Sawada D; Arai MA; Takagi K; Chida T; Harada Y; Saito H; Takenouchi K; Ishizuka S; Hayashi K; Ikushiro S; Sakaki T; Sugiura T; Chen TC
    Anticancer Res; 2009 Sep; 29(9):3563-9. PubMed ID: 19667149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of 1alpha,25-dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed.
    Siu-Caldera ML; Sekimoto H; Weiskopf A; Vouros P; Muralidharan KR; Okamura WH; Bishop J; Norman AW; Uskoković MR; Schuster I; Reddy GS
    Bone; 1999 May; 24(5):457-63. PubMed ID: 10321905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and metabolism of F6-1alpha,25(OH)2 vitamin D3 and 1alpha,25(OH)2 vitamin D3 in the parathyroid glands of rats dosed with tritium-labeled compounds.
    Komuro S; Sato M; Kanamaru H
    Drug Metab Dispos; 2003 Aug; 31(8):973-8. PubMed ID: 12867483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
    Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
    J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileukemic effect of a synthetic vitamin D3 analog, HY-11, with low potential to cause hypercalcemia.
    Yoon JS; Kim JY; Park HK; Kim ES; Ahn KS; Yoon SS; Cho CG; Kim BK; Lee YY
    Int J Oncol; 2008 Feb; 32(2):387-96. PubMed ID: 18202761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of a 3-position diastereomer of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71).
    Hatakeyama S; Nagashima S; Imai N; Takahashi K; Ishihara J; Sugita A; Nihei T; Saito H; Takahashi F; Kubodera N
    Bioorg Med Chem; 2006 Dec; 14(23):8050-6. PubMed ID: 16908172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
    J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.